|Articles|November 1, 2016 (Updated: November 15, 2020)
- Pharmaceutical Executive-11-01-2016
- Volume 36
- Issue 11
Pharmaceutical Executive, November 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Pharm Exec's 2017 Pipeline Reportover 9 years ago
Digital Disruption is Coming: Are You Ready?over 9 years ago
8 Winning Commercial Portfolio Strategiesover 9 years ago
Building Market Access Competencies for the Futureover 9 years ago
Loss of Exclusivity: Strategies to Maximize Product Valueover 9 years ago
Flipping the Generics Map: Apotex's Jeremy Desaiover 9 years ago
The Pipeline: Pressures from Beyondover 9 years ago
Has Gastein Peaked?over 9 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5